Videos

In this episode of Drug Digest, Pharmaceutical Technology editors discuss what happens in early phase development, the role of CDMOs, and highlight the benefits and challenges of the outsourcing process. 

Drug Digest: Early Phase Development and CDMOs in the Outsourcing Landscape

Feliza Mirasol is the science editor for 

Chris Spivey is the editorial director of 

In this episode of Drug Digest, Pharmaceutical Technology editors discuss the advantages and savings that continuous manufacturing may offer as well as the very real obstacles that might make a fully continuous process not feasible, especially in biologics manufacturing.

Drug Digest: Advancements in the Implementation of Continuous Manufacturing

In this episode of Drug Digest, Grant Playter, associate editor, speaks with computer validation experts on how to set data controls and why efforts spent here are financially rewarding in the long run.

Drug Digest: Unpacking the Science Behind Data Integrity

Drug Digest: FDA Quality Management Maturity (QMM) Overseas Pilot Program Findings

Meg Rivers is the former senior editor for 

Pharmaceutical Technology editors interview an automation expert from Automata on the benefits of automating entire workflows in analytics versus automating only specific pieces of equipment or only certain processes.

Drug Digest: Automation in Biopharma and the Impact on Workflows

Editor of Pharmaceutical Technology Europe

Pharmaceutical Technology editors interview oral solid dosage development experts from Syntegon and Colorcon, with discussions centered on continuous OSD production, containment safety, and authentication at the dose level.

Drug Digest: Advancing OSD: Continuous Production Considerations and Dose-Level Authentication

Pharmaceutical Technology editors interview aseptic and sterilization experts from Watson-Marlow Fluid Technology Solutions and Cherwell—diving into sterilization, aseptic processing, and the revised EU GMP Annex 1 guidance.

Drug Digest: Sterilization’s Horizon: Improving Automation, Single-Use Technologies, and Annex 1

In this exclusive Drug Digest video, experts from Roche and MilliporeSigma divulge factors that could influence an organization to pursue specific biomolecules for development.